Mini-monoka punctocanaliculoplasty manages canalicular stenosis

Article

Epiphora secondary to punctal and canalicular stenosis is successfully managed by mini-monoka punctocanaliculoplasty.

Epiphora secondary to punctal and canalicular stenosis is successfully managed by mini-monoka punctocanaliculoplasty, according to a study in the British Journal of Ophthalmology.

Dr R.N. Hussain et al., Department of Ophthalmology, Leicester Royal Infirmary, Infirmary Square, Leicester, UK, performed a retrospective case note analysis on 123 eyes of 77 consecutive patients.

Of the eyes studied, 73% had punctal stenosis, 72% had canalicuar stenosis, 46% had both punctal stenosis and canalicuar stenosis, 20% had some severity of lid laxity and 29% had nasolacrimal duct stenosis.

After treatment, 82% of the eyes demonstrated a significant improvement in symptoms. The success rate was raised to 88% when structural comorbidity patients were excluded from the study.

It was discovered that mini-monoka punctocanaliculoplasty is an effective, safe, simple and fairly non-invasive treatment for epiphora secondary to punctal and/or canalicular stenosis.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.